513 related articles for article (PubMed ID: 25400825)
21. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.
Peng H; Li Y; Wang C; Zhang J; Chen Y; Chen W; Cao J; Wang Y; Hu Z; Lou T
Sci Rep; 2016 Feb; 6():20304. PubMed ID: 26842599
[TBL] [Abstract][Full Text] [Related]
22. The glucocorticoid dexamethasone inhibits U937 cell adhesion and neutrophil release via RhoA/ROCK1-dependent and independent pathways.
Liu D; Xiong R; Chen X; Li P; Ning Y; Peng Y; Zhao Y; Yang N; Zhou Y
Cell Physiol Biochem; 2014; 33(6):1654-62. PubMed ID: 24902944
[TBL] [Abstract][Full Text] [Related]
23. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
Eisa-Beygi S; Wen XY
Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
[TBL] [Abstract][Full Text] [Related]
24. Activation of Rho kinase isoforms in lung endothelial cells during inflammation.
Mong PY; Wang Q
J Immunol; 2009 Feb; 182(4):2385-94. PubMed ID: 19201893
[TBL] [Abstract][Full Text] [Related]
25. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
26. Nogo receptor knockdown and ciliary neurotrophic factor attenuate diabetic retinopathy in streptozotocin-induced diabetic rats.
Guo X; Liu X
Mol Med Rep; 2017 Aug; 16(2):2030-2036. PubMed ID: 28656312
[TBL] [Abstract][Full Text] [Related]
27. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.
Rigassi L; Barchiesi Bozzolo F; Lucchinetti E; Zaugg M; Fingerle J; Rosselli M; Imthurn B; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2015 Dec; 309(12):E995-1007. PubMed ID: 26487003
[TBL] [Abstract][Full Text] [Related]
28. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
Wang J; Liu H; Chen B; Li Q; Huang X; Wang L; Guo X; Huang Q
Cardiovasc Diabetol; 2012 Jan; 11():7. PubMed ID: 22251897
[TBL] [Abstract][Full Text] [Related]
29. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
Mishra M; Flaga J; Kowluru RA
J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
[TBL] [Abstract][Full Text] [Related]
30. p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy.
Zou W; Zhang Z; Luo S; Cheng L; Huang X; Ding N; Yu J; Pan Y; Wu Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319515
[TBL] [Abstract][Full Text] [Related]
31. Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell.
Zhao MJ; Jiang HR; Sun JW; Wang ZA; Hu B; Zhu CR; Yin XH; Chen MM; Ma XC; Zhao WD; Luan ZG
Front Immunol; 2021; 12():697071. PubMed ID: 34745088
[TBL] [Abstract][Full Text] [Related]
32. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway.
Dasgupta SK; Le A; Vijayan KV; Thiagarajan P
Cancer Med; 2017 Apr; 6(4):809-818. PubMed ID: 28316141
[TBL] [Abstract][Full Text] [Related]
33. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
35. miR‑133b regulates proliferation and apoptosis in high‑glucose‑induced human retinal endothelial cells by targeting ras homolog family member A.
Yao J; Wang J; Yao Y; Wang K; Zhou Q; Tang Y
Int J Mol Med; 2018 Aug; 42(2):839-850. PubMed ID: 29786744
[TBL] [Abstract][Full Text] [Related]
36. A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats.
Wei L; Sun D; Yin Z; Yuan Y; Hwang A; Zhang Y; Si R; Zhang R; Guo W; Cao F; Wang H
Apoptosis; 2010 Apr; 15(4):488-98. PubMed ID: 20044781
[TBL] [Abstract][Full Text] [Related]
37. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.
Allen C; Srivastava K; Bayraktutan U
Stroke; 2010 Sep; 41(9):2056-63. PubMed ID: 20651275
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation.
Lu Q; Harrington EO; Jackson H; Morin N; Shannon C; Rounds S
J Appl Physiol (1985); 2006 Aug; 101(2):375-84. PubMed ID: 16645187
[TBL] [Abstract][Full Text] [Related]
39. ROCK1 feedback regulation of the upstream small GTPase RhoA.
Tang AT; Campbell WB; Nithipatikom K
Cell Signal; 2012 Jul; 24(7):1375-80. PubMed ID: 22430126
[TBL] [Abstract][Full Text] [Related]
40. Extracellular heat shock protein 90α mediates HDM-induced bronchial epithelial barrier dysfunction by activating RhoA/MLC signaling.
Dong HM; Le YQ; Wang YH; Zhao HJ; Huang CW; Hu YH; Luo LS; Wan X; Wei YL; Chu ZQ; Li W; Cai SX
Respir Res; 2017 May; 18(1):111. PubMed ID: 28558721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
